5176 - 5200 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 41
-
OPENTitle: Tau immunoreactivity in peripheral tissues of human aging and select tauopathiesJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 696Issue #:Start Page: 132End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2018.12.031Best OA location URL: https://europepmc.org/articles/pmc7357994?pdf=renderCitation Count: 40
- Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.2019RESTRICTEDTitle: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 3Start Page: 391End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000503Citation Count: 24
- Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways2019OPENTitle: Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathwaysJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0675-9Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0675-9Citation Count: 15
-
OPENTitle: Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)Journal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 266Issue #: 5Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-019-09250-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-019-09250-y.pdfCitation Count: 16
-
OPENTitle: Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 2Start Page: 301End Page: 313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191576Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191576?id=journal-of-parkinsons-disease%2Fjpd191576Citation Count: 104
- LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice2019OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 42
- Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease2019OPENTitle: Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 5Start Page: 704End Page: 714Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25450Best OA location URL: https://doi.org/10.1002/ana.25450Citation Count: 122
-
RESTRICTEDTitle: Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T CellsJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00303Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00303/pdfCitation Count: 121
-
RESTRICTEDTitle: Dual threshold neural closed loop deep brain stimulation in Parkinson disease patientsJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 868End Page: 876Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.02.020Citation Count: 194
- Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity2019RESTRICTEDTitle: Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese NeurotoxicityJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 4Start Page: 994End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20040994Best OA location URL: https://www.mdpi.com/1422-0067/20/4/994/pdf?version=1551081390Citation Count: 19
- Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity2019OPENTitle: Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activityJournal Name: Molecular MetabolismPublisher: Elsevier BVVol: 24Issue #:Start Page: 120End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.molmet.2019.02.005Best OA location URL: https://doi.org/10.1016/j.molmet.2019.02.005Citation Count: 11
- Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase2019RESTRICTEDTitle: Correction to Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 5Start Page: 2850End Page: 2850Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.9b00284Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00284Citation Count: 0
-
OPENTitle: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriersJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 8Start Page: 2546End Page: 2555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24543Best OA location URL: https://europepmc.org/articles/pmc6865680?pdf=renderCitation Count: 20
-
OPENTitle: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 526End Page: 535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27642Best OA location URL: https://europepmc.org/articles/pmc6469643?pdf=renderCitation Count: 92
- Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred2019RESTRICTEDTitle: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindredJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 133End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024Citation Count: 2
- High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra2019OPENTitle: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia NigraJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 291Issue #: 1Start Page: 149End Page: 157Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1148/radiol.2019181042Best OA location URL: https://europepmc.org/articles/pmc6438360?pdf=renderCitation Count: 42
- Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect Thresholds2019OPENTitle: Awake Testing during Deep Brain Stimulation Surgery Predicts Postoperative Stimulation Side Effect ThresholdsJournal Name: Brain SciencesPublisher: MDPI AGVol: 9Issue #: 2Start Page: 44End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci9020044Best OA location URL: https://www.mdpi.com/2076-3425/9/2/44/pdf?version=1550479268Citation Count: 12
-
RESTRICTEDTitle: T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00239Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00239/pdfCitation Count: 97
-
RESTRICTEDTitle: Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 593End Page: 599Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25436Citation Count: 49
-
OPENTitle: Progressive brain atrophy in chronically infected and treated HIV+ individualsJournal Name: Journal of NeuroVirologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 3Start Page: 342End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13365-019-00723-4Best OA location URL: https://europepmc.org/articles/pmc6635004?pdf=renderCitation Count: 30
- OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trial2019OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/records/3832127/files/R1-OnabotulinumtoxinA_and_Cognitive_Behavioral_Therapy_in_Functional_Dystonia_A_Pilot_Randomized_Clinical_Trial_pdf.io.pdfCitation Count: 15
-
RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 6
-
RESTRICTEDTitle: Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseasesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 7Start Page: 329End Page: 337Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000006926Best OA location URL: https://europepmc.org/articles/pmc6382364?pdf=renderCitation Count: 196
- Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s disease2019OPENTitle: Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 2Start Page: e0211699End Page: e0211699Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0211699Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0211699&type=printableCitation Count: 8